Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Celadon Pharmaceuticals is navigating financial uncertainties as it awaits £0.5 million from its credit facility, contingent on an investment sale by its lender. With current cash reserves of £0.3 million, the company expects to sustain operations until January 2025 and is exploring alternative financing options to secure its future.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.